A detailed history of Org Partners LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Org Partners LLC holds 48 shares of MRNA stock, worth $2,650. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48
Previous 51 5.88%
Holding current value
$2,650
Previous $6,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$63.64 - $125.14 $190 - $375
-3 Reduced 5.88%
48 $3,000
Q2 2024

Jul 16, 2024

BUY
$101.21 - $166.61 $4,250 - $6,997
42 Added 466.67%
51 $6,000
Q1 2024

May 06, 2024

BUY
$85.37 - $115.44 $170 - $230
2 Added 28.57%
9 $0
Q4 2023

Jan 29, 2024

SELL
$69.51 - $104.43 $3,266 - $4,908
-47 Reduced 87.04%
7 $0
Q3 2023

Nov 03, 2023

SELL
$96.41 - $126.61 $289 - $379
-3 Reduced 5.26%
54 $5.15 Million
Q2 2023

Jul 25, 2023

BUY
$118.5 - $160.53 $6,754 - $9,150
57 New
57 $7.34 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $21.6B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Org Partners LLC Portfolio

Follow Org Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Org Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Org Partners LLC with notifications on news.